Skip to Content
Full Title A Randomized, Placebo-controlled, Prospective, Double-blind, Multicenter Phase 2/3 Study of the Efficacy and Safety of SANGUINATE™ for Reduction of Delayed Graft Function in Recipients of a Donation After Brain Death Kidney Transplant
Protocol Number SGTP-002
Principal Investigator(s) David P Foley, MD
Division Transplantation
Status Recruiting

Safety and efficacy study of SANGUINATE on reduction of delayed graft function (DGF) in patients who will be recipients of a donation after brain death (DBD) donor kidney.

Other Clinical Trials in the Department of Surgery Copyright © 2016 The Board of Regents of the University of Wisconsin System